Turning Point Benefit Group, Inc. Abb Vie Inc. Transaction History
Turning Point Benefit Group, Inc.
- $166 Billion
- Q3 2025
A detailed history of Turning Point Benefit Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Turning Point Benefit Group, Inc. holds 871 shares of ABBV stock, worth $203,814. This represents 0.13% of its overall portfolio holdings.
Number of Shares
871Holding current value
$203,814% of portfolio
0.13%Shares
1 transactions
Others Institutions Holding ABBV
# of Institutions
4,481Shares Held
1.28BCall Options Held
17.1MPut Options Held
15.4M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...